The government is on track to approve a new antibiotic to treat a pneumonia-like disease in cattle, despite warnings from health groups and a majority of the Food and Drug Administration's scientific advisers that the decision will be dangerous for people.

The drug, called cefquinome , belongs to a class of highly potent antibiotics that are among medicine's last defense against several serious human infections. No drug from that class has been approved in the United States for use in animals.

The American Medical Association and about a dozen other health groups warned the FDA that giving cefquinome to animals would probably speed the emergence of microbes resistant to that class of antibiotic, as has happened with other drugs. Those super-microbes could then spread to people.

Echoing those concerns, the FDA's advisory board last fall voted to reject the request by InterVet Inc. of Millsboro, Del., to market the drug for cattle.

But the FDA is expected to approve cefquinome this spring. That outcome is all but required, officials said, by a recently implemented "guidance document" that codifies how to weigh threats to human health posed by proposed new animal drugs.

Industry representatives say they trust Guidance 152's calculation that cefquinome should be approved. But others say Guidance 152 makes it too difficult for the FDA to say no to some drugs because it requires that the agency show a direct link to human mortality

An African-American attorney is suing the Los Angeles law firm founded by the late Johnnie Cochran over alleged racial discrimination.

The Los Angeles Times said Saturday that Shawn Chapman Holley has said that after Cochran's death in 2005, the firm's leadership was turned over to "white men who began to discriminate against black lawyers and black clients."

Prior to Cochran's death, the law firm gained notoriety for the acquittal of 1994 double murder charges against O.J. Simpson. The lawsuit has stunned members of the city's black establishment, the Times said.

Public affairs consultant Kerman Maddox, told the Times, "I'm shocked; if true, that would be a devastating blow to the legacy of Johnnie Cochran."

Randy McMurray, a black partner in the firm, denied Holley's charges. "We probably have the most diverse law firm in California; I don't know what race we would be discriminating against," he said.

Holley worked for the firm for some 17 years before she says she was demoted by Caucasian males and then fired in January of 2006, an allegation the firm has denied.

The firings have sparked arguments about the power of the US Attorney General to indefinitely appoint replacement prosecutors, and also allegations that the firings were politically charged. Earlier this week Iglesias told reporters that federal lawmakers pressured him to speed up indictments of local Democrats in time for the November elections. In testimony before the Senate Judiciary Committee last month, Deputy Attorney General Paul McNulty denied that the removal of the attorneys was motivated by political considerations.

A three judge panel of the US Court of Appeals for the Sixth Circuit threw out a lawsuit challenging Ohio's death penalty procedure Friday on the grounds that the claim was filed too late. In the 2-1 opinion, judges Richard Fred Suhrheinrich and Edward Eugene Siler decided that the statute of limitations on the inmate's 42 USC 1983 method of execution challenge would have run at the latest two years following the 2001 decision that made lethal injection Ohio's only form of execution. Plaintiff Cooey did not file his challenge until December of 2004.

Last year Ohio executed its first prisoner using modified lethal injection procedures aimed at preventing extreme pain during an execution. The procedures were changed last June following a difficult May execution where staff struggled to find a vein to administer the lethal injection cocktail, and the one they did use collapsed before injection.

The US Dept. of Homeland Security (DHS) Thursday agreed to extend by 18 months the compliance timeline for the REAL ID Act until December 31, 2009. In addition to the extension of the deadline imposed on states, DHS will allow states to use as much as 20 percent of the money allocated by the agency to ensure compliance. The proposed changes follow resistance by state and federal lawmakers, who questioned the feasibility of implementing uniform driver's license standards under the act before the original May 2008 deadline, and aim at assuaging concerns over the cost of the new regulations.

The REAL ID Act, initially drafted after the Sept 11 attacks and designed to discourage illegal immigration, attempts to make it more difficult for terrorists to fraudulently obtain US driver's licenses and other government IDs by mandating that states require birth certificates or similar documentation and also consult national immigration databases before issuing IDs. The law is also meant to make it more difficult for potential terrorists to board aircraft or enter federal government buildings. After controversy and strenuous opposition from civil libertarians it finally passed in 2005 as part of an emergency supplemental appropriations defense spending bill.

A federal judge in California on Thursday dismissed all claims in the second of four patent infringement lawsuits filed by Alcatel-Lucent against Microsoft Corp. . The case, which was scheduled to begin trial March 19, concerned speech recognition technology. The ruling, issued by US District Judge Rudi Brewster, will be appealed by Alcatel-Lucent.

Last Thursday, a federal jury in California awarded Alcatel-Lucent $1.52 billion in damages for violations of two of Alcatel-Lucent's digital music patents committed by Microsoft. Microsoft indicated it might appeal the verdict. Two additional patent suits between Microsoft and Alcatel-Lucent are pending, with the next trial scheduled to begin May 21.

Belgium has become the first country to criminalize investment in companies that make cluster bombs. Legislation passed the Belgian Senate on Thursday, and the Parliament plans to publish a list of companies that manufacture cluster munitions. Belgian banks KBC and Fortis have already terminated their investments in such companies, and KBC has published its own list of manufacturers. The new law will prohibit Belgian banks from owning shares in cluster bomb manufacturers or offering them credit.

Last week, 46 countries pledged to develop a new international treaty to ban the use of cluster bombs by 2008 at the Oslo Conference on Cluster Munitions. Last year, Belgium was the first country to ban cluster bombs. Although the US did not attend the Oslo conference, top Democratic lawmakers recently introduced a bill in the US Senate that would ban federal funds for the use, sale or transfer of cluster bombs. Cluster munitions, which have been used by at least 23 countries, are considered by many to be inaccurate weapons designed to spread damage indiscriminately and could therefore be considered illegal under multiple provisions of Protocol I of the Geneva Conventions (1977).